US2013189211A1PendingUtilityA1

Cosmetic Compositions

57
Assignee: JAN MARINI SKIN RESPriority: May 30, 2008Filed: Oct 18, 2012Published: Jul 25, 2013
Est. expiryMay 30, 2028(~1.8 yrs left)· nominal 20-yr term from priority
Inventors:Jan L. Marini
A61K 38/08A61Q 7/00A61K 38/07A61K 8/64A61Q 5/00
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention generally features novel cosmetic skin and hair care compositions for enhancing the appearance of eyelashes and eyebrows. Specifically, the topical skin and hair care compositions of the invention contain a concentration of at least one of pentapeptide-17 tetrapeptide-12 that provide for thicker, longer and more voluminous appearing eyelashes and eyebrows. The cosmetic formulations of the invention may further include cosmetically acceptable vehicle(s) and/or other skin and hair conditioning agents.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A cosmetic composition for topical application comprising:
 at least one of acylated tetrapeptide-12 or acylated pentapeptide-17 at a concentration of from about 0.001 μg/ml to about 1 μg/ml; and   a cosmetically acceptable vehicle.   
     
     
         2 . The cosmetic formulation of  claim 1 , comprising from about 0.001 μg/ml to about 1 μg/ml of pentapeptide-17, wherein pentapeptide-17 is a five amino acid peptide having the amino acid sequence Ac-KLAKK. 
     
     
         3 . The cosmetic formulation of  claim 2 , wherein pentapeptide-17 comprises an amide terminus. 
     
     
         4 . The cosmetic formulation of  claim 2 , wherein pentapeptide-17 comprises an acyl group selected from an octanoyl, decanoyl, lauroyl, myristoyl, palmitoyl, stearoyl, oleoyl, linoleoyl, or arachidonoyl group. 
     
     
         5 . The cosmetic formulation of  claim 2 , wherein pentapeptide-17 comprises a carboxy terminal myristoyl group. 
     
     
         6 . The cosmetic formulation of  claim 2 , further comprising from about 0.001 μg/ml to about 1 μg/ml of tetrapeptide-12, wherein tetrapeptide-12 is a four amino acid peptide having the amino acid sequence Ac-KAKA. 
     
     
         7 . The cosmetic formulation of  claim 6 , wherein the ratio of pentapeptide-17:tetrapeptide-12 is from 10:1 to about 1:10. 
     
     
         8 . The cosmetic formulation of  claim 7 , wherein the ratio of pentapeptide-17:tetrapeptide-12 is about 4:1. 
     
     
         9 . The cosmetic composition of  claim 1 , wherein the pH of said composition is in the range of about pH 3 to about pH 7. 
     
     
         10 . The cosmetic composition of  claim 1 , provided in a closed container having a fine brush applicator. 
     
     
         11 . A method for treating skin, scalp or hair comprising:
 applying to said skin, scalp or hair a composition comprising:   at least one of acylated tetrapeptide-12 or acylated pentapeptide-17 at a concentration of from about 0.001 μg/ml to about 1 μg/ml; and   a cosmetically acceptable vehicle.   
     
     
         12 . The method of  claim 11 , wherein the cosmetic formulation comprises from about 0.001 μg/ml to about 1 μg/ml of pentapeptide-17, wherein pentapeptide-17 is a five amino acid peptide having the amino acid sequence Ac-KLAKK. 
     
     
         13 . The method of  claim 11 , wherein pentapeptide-17 comprises an amide terminus. 
     
     
         14 . The method of  claim 11 , wherein pentapeptide-17 comprises an acyl group selected from an octanoyl, decanoyl, lauroyl, myristoyl, palmitoyl, stearoyl, oleoyl, linoleoyl, or arachidonoyl group. 
     
     
         15 . The method of  claim 11 , wherein pentapeptide-17 comprises a carboxy terminal myristoyl group. 
     
     
         16 . The method of  claim 11 , wherein the cosmetic formulation further comprises from about 0.001 μg/ml to about 1 μg/ml of tetrapeptide-12, wherein tetrapeptide-12 is a four amino acid peptide having the amino acid sequence Ac-KAKA. 
     
     
         17 . The method of  claim 11 , wherein the ratio of pentapeptide-17:tetrapeptide-12 in the cosmetic formulation is from 10:1 to about 1:10. 
     
     
         18 . The method of  claim 11 , wherein the ratio of pentapeptide-17:tetrapeptide-12 in the cosmetic formulation is about 4:1. 
     
     
         19 . The method of  claim 11 , wherein the pH of said composition is in the range of about pH 3 to about pH 7. 
     
     
         20 . The method of  claim 11 , wherein the cosmetic formulation is applied to the skin comprising the hair of the eyelashes and/or eyebrows.

Join the waitlist — get patent alerts

Track US2013189211A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.